Movado Group Inc. (NYSE: MOV) shares are seeing a huge rally in today’s trading after the company released its fourth-quarter financial results, securing gains of more than 12% on the day. Movado reported fourth-quarter adjusted income from continuing operations of $1.3 million, or $0.05 per share, compared with an adjusted loss from continuing operations of [...]
Articles published by james.vale
Banking Stock Review; 3 Cheap, Small-cap Finance Stocks
Harvard Illinois Bancorp Inc. (OTC: HARI) is a bank holding company. It carries out its operations through its subsidiary Harvard Savings Bank to offer a wide range of services such as mortgage and banking features. It serves corporate and individual customers. The company is based out of Illinois. The company stock is currently trading at [...]
Cheap Stock; BioAVI Biopharma plummets on Public Offering
AVI BioPharma Inc. (NASDAQ: AVII) today announced the public offering of 20 million shares of its common stock priced at $1.50 per share for gross proceeds of $30.0 million. The net proceeds from the offering are expected to be approximately $27.8 million after deducting the underwriters’ discounts and other estimated offering expenses payable by the [...]
Organ Preservation; Allezoe Patent News not enough to keep Shares Alive
Allezoe Medical Holdings (OTC: ALZM) shares has been granted European patent protection for its donor organ preservation technology; the news sent shares into an all-day rally yesterday, then dropped nearly 5% in today’s trade. Allezoe Medical acquired this protection via its subsidiary Organ Transport Systems (OTS). The company said that the technology will help in [...]
Biotech Stock News – Dendreon Investor Anxiety eased on Positive Medicare Ruling
Dendreon Corp. (NASDAQ: DNDN) today announced that it has won a Medicare ruling that says the company’s prostate cancer drug Provenge is eligible for Medicare reimbursement. News of the approval lifted a blanket of investor anxiety that weighed shares down since last summer, with the stock gaining more than 5% mid-day. Christopher Raymond, an analyst [...]
Movie Deals worth Watching – Netflix expands Movie Library with Paramax Contract
Netflix Inc. (NASDAQ: NFLX) has inked a new multi-year licensing agreement for Canada with Paramax, which is a division of Viacom (NYSE: VIA). The deal is expected to add hundreds of new movie titles for Canadian customers. Financial terms of the Netflix/Viacom deal were not disclosed. Netflix is also in talks with Miramax, and sources [...]
Hot Nasdaq Stock; Starbucks brews Strategic Growth Plans
Starbucks Corp. (NASDAQ: SBUX) secured gains on the day shortly after the popular coffee hot spot revealed its growth plans for the future in its recent 20th annual shareholders’ meeting. The company reiterated its focus on building a global consumer company by having a portfolio of brands with a unique business model, combining its global [...]
Hot Biotech Stock; Gilead Sciences announces Positive Phase III Study of HIV Drug
Gilead Sciences Inc. (NASDAQ: GILD) shares gained ground after the company announced that its investigational antiretroviral agent elvitegravir for the treatment of HIV-1 infection met its primary objective in phase III clinical trial. Elvitegravir is a new oral integrase inhibitor being evaluated for the treatment of HIV-1 infection in treatment-experienced adults with viral load greater [...]
Opportunity in Disaster: URRE Buy, Sell or Hold?
I like buying beat-down stocks. This is particularly true when the selling is triggered by irrational fear in an industry critical for the global infrastructure. Every so often opportunities arise that are custom made for bottom fishers in the stock market. The Japanese tragedy created one of these chances for buying the fear. While the [...]